论文部分内容阅读
目的:探讨小儿肺炎支原体肺炎的临床诊治方法及其应用效果,为以后的医疗实践提供可靠的科学依据。方法:于2014年6月至2014年11月期间,选取我院儿科住院部收治的84例小儿肺炎支原体肺炎患儿,将其依据数字表法分为研究组与对照组等两个不同组别,各组别病例数均为42例,其中前组别患儿均采用阿奇霉素治疗,后组别患儿均采用红霉素治疗,用药后观察并对比两种不同治疗方法的临床应用效果。结果:治疗后,研究组与对照组患者治疗总有效率分别为97.6%和83.3%,患儿不良反应发生率分别为4.8%和19.0%,两组患儿两项指标数据比较均存在明显统计学差异(P<0.05)。结论:小儿肺炎支原体肺炎采用阿奇霉素治疗,可有效缓解或改善患儿的各项临床症状,降低其不良反应发生率,治疗效果良好,具有较高的临床推广与应用价值。
Objective: To explore the clinical diagnosis and treatment of children with Mycoplasma pneumoniae pneumonia and its application effects, and to provide reliable scientific basis for future medical practice. Methods: From June 2014 to November 2014, 84 children with mycoplasma pneumoniae pneumonia admitted in pediatric inpatient department of our hospital were selected and divided into two groups (study group and control group) , The number of cases in each group were 42 cases, of which the former group of children were treated with azithromycin, the latter group of children were treated with erythromycin, after treatment observed and compared the clinical effects of two different treatment methods. Results: After treatment, the total effective rates of treatment group and control group were 97.6% and 83.3% respectively, and the incidences of adverse reactions in children were 4.8% and 19.0% respectively. There was significant statistical difference between the two indexes in both groups Learning difference (P <0.05). Conclusion: Mycoplasma pneumoniae pneumonia treatment with azithromycin can effectively alleviate or improve the clinical symptoms of children, reduce the incidence of adverse reactions, the treatment effect is good, with high clinical value and clinical application.